Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a ...

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market ...

Advancements in insulin pens help the growth of the market. Smart insulin pens are digital; through the internet, pens automatically share information about the time and amount of insulin received ...

along with the company’s smart insulin pen. At that time, Medtronic also announced a global partnership with Abbott, where Abbott would supply an integrated CGM based on its FreeStyle Libre ...

Smart Insulin, also known as Glucose Responsive Insulin ... Advanced diabetic therapy in the form of insulin patches, insulin pens, continuous glucose monitoring systems (CGMS), and artificial ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.